Green tea polyphenol extract attenuates zymosan-induced non-septic shock in mice

Shock

Volumn 26, Issue 4, 2006, Pages 402-409

  Di Paola, Rosanna ^a   Mazzon, Emanuela ^a,b   Muià, Carmelo ^a   Crisafulli, Concetta ^a   Genovese, Tiziana ^a,b   Di Bella, Paolo ^b   Esposito, Emanuela ^c   Menegazzi, Marta ^d   Meli, Rosaria ^c   Suzuki, Hisanori ^d   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

Green Tea polyphenol extract; Inducible nitric oxide synthase (iNOS); MODS; Nitrotyrosine; Zymosan induced non septic shock

Indexed keywords

3 NITROTYROSINE; GREEN TEA EXTRACT; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); POLYPHENOL; SODIUM CHLORIDE; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE; KIDNEY DISEASE; LIVER DISEASE; LIVER INJURY; LUNG; LUNG INJURY; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PANCREAS INJURY; PERITONEUM EXUDATE; POLYMORPHONUCLEAR CELL; SHOCK; STAINING; WEIGHT REDUCTION;

ANIMALS; CAMELLIA SINENSIS; FLAVONOIDS; MALE; MICE; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; SHOCK; WEIGHT LOSS; ZYMOSAN;

EID: 33748755550     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000191379.62897.1d     Document Type: Article

References (41)

1. Seely AJ, Christou NV: Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 28:2193-2200, 2000.
2. Marshall JC: Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29:S99-S106, 2001.
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
4. Deitch EA: Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 216:117-134, 1992.
5. Regel G, Grotz M, Weltner T, Sturm JA, Tscherne H: Pattern of organ failure following severe trauma. World J Surg 20:422-429, 1996.
6. Davies MG, Hagen PO: Systemic inflammatory response syndrome. Br J Surg 84:920-935, 1997.
7. Pan MH, Lin-Shiau SY, Ho CT, Lin JH, Lin JK: Suppression of lipopolysaccharide-induced nuclear factor-kappaB activity by theaflavin-3,3-digallate from black tea and other polyphenols through down-regulation of IkappaB kinase activity in macrophages. Biochem Pharmacol 59:357-367, 2000.
8. Serafini M, Ghiselli A, Ferro-Luzzi A: In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 50:28-32, 1996.
9. Dona M: Neutrophil restraint by green tea: Inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol 170:4335-4341, 2003.
10. Levites Y, Amit T, Youdim MB, Mandel S: Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 277:30574-30580, 2002.
11. Chan MM, Fong D, Ho CT, Huang HI: Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem Pharmacol 54:1281-1286, 1997.
12. Kim HS: EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells. Anticancer Res 24:747-753, 2004.
13. Yang F, de Villiers WJS, McClain CJ, Varilek GW: Green tea polyphenols block endotoxin-induced tumor necrosis factor-α production and lethality in a murine model. J Nutr 128:2334-2340, 1998.
14. Anthony DD, Gupta S, Ahmad N, Lee M-S, Kumar GK, Mukhtar H: Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A 96:4524-4529, 1999.
15. Varilek GW, Yang F, Lee EY, Schweder D, McClain CJ: Green Tea attenuates inflammation and severity of colitis in IL-2 deficient mice. Gastroenterology 116:836, 1999.
16. Cuzzocrea S, Imperatore F, Costantino G, Luongo C, Mazzon E, Scafuro MA, Mangoni G, Caputi AP, Rossi F, Filippelli A: Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat. Shock 13:197-203, 1999.
17. Mullane KM, Westlin W, Kraemer R: Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. Ann NY Acad Sci 524:103-121, 1988.
18. Baue AE: The multiple organ or system failure syndrome. In Schlag G, Redl H (eds.): Pathophysiology of Shock, Sepsis, and Organ Failure. Berlin: Springer Verlag, pp 1004-1018, 1993.
19. Thiemermann C, Ruetten H, Wu CC: The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116:2845-2851, 1995.
20. Ruetten H, Thiemermann C: Effect of calpain inhibitor I, an inhibitor of the proteolysis of I_B, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Br J Pharmacol 121:695-704, 1997.
21. Goris RJ, Boekholtz WK, van Bebber IP, Nuytinck JK, Schillings PH: Multiple-organ failure and sepsis without bacteria. An experimental model. Arch Surg 121:897-901, 1986.
22. Pillemer L, Ecker EE: Anticomplementary factor in fresh yeast. J Biol Chem 137:139-142, 1941.
23. Humes JL, Sadowski S, Galavage M, Goldenberg M, Subers E, Bonney RJ, Kuehl FAJ: Evidence for two sources of arachidonic acid for oxidative metabolism by mouse peritoneal macrophages. J Biol Chem 257:1591-1594, 1982.
24. Roubin R, Mencia Huerta JM, Landes A, Benveniste J: Biosynthesis of platelet-activating factor (PAF-acether). IV. Impairment of acetyl-transferase activity in thioglycollate-elicited mouse macrophages. J Immunol 129:809-813, 1982.
25. Nauseef WM, Root RK, Newman SL, Malech HL: Inhibition of zymosan activation of human neutrophil oxidative metabolism by a mouse monoclonal antibody. Blood 62:635-644, 1983.
26. Bonney RJ, Wightman PD, Davies P, Sadowski SJ, Kuehl FAJ, Humes JL: Regulation of prostaglandin synthesis and of the selective release of lysosomal hydrolases by mouse peritoneal macrophages. Biochem J 176:433-442, 1978.
27. Underhill DM: Macrophage recognition of zymosan particles. J Endotoxin Res 9:176-180, 2003.
28. Sato M, Sano H, Iwaki D, Kudo K, Konishi M, Takahashi H, Takahashi T, Imaizumi H, Asai Y, Kuroki Y: Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. J Immunol 171:417-425, 2003.
29. Kelly BA, Carchman RA: The relationship between lysosomal enzyme release and protein phosphorylation in human monocytes stimulated by phorbol esters and opsonized zymosan. J Biol Chem 262:17404-17411, 1987.
30. Daum T, Rohrbach MS: Zymosan induces selective release of arachidonic acid from rabbit alveolar macrophages via stimulation of a beta-glucan receptor. FEBS Lett 309:119-122, 1992.
31. Sanguedolce MV, Capo C, Bongrand P, Mege JL: Zymosan-stimulated tumor necrosis factor-alpha production by human monocytes. Down-modulation by phorbol ester. J Immunol 148:2229-2236, 1992.
32. Shayevitz JR, Miller C, Johnson KJ, Rodriguez JL: Multiple organ dysfunction syndrome: end organ and systemic inflammatory response in a mouse model of nonseptic origin. Shock 4:389-396, 1995.
33. Deng X, Wang X, Andersson R: Alterations in endothelial barrier permeability in multiple organs during overactivation of macrophages in rats. Shock 6:126-133, 1996.
34. Lefer AM, Lefer DJ: Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Ann Rev Pharmacol Toxicol 33:71-90, 1993.
35. Cuzzocrea S, Filippelli A, Zingarelli B, Falciani M, Caputi AP, Rossi F: Role of nitric oxide in a nonseptic shock model induced by zymosan in the rat. Shock 7:351-357, 1997.
36. Cuzzocrea S, Mazzon E, Dugo L, Barbera A, Centorrino T, Ciccolo A, Fonti MT, Caputi AP: Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan. Shock 16:51-58, 2001.
37. Eiserich JP, Hristova M, Cross CE: Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393-397, 1998.
38. Yao YM, Redl H, Bahrami S, Schlag G: The inflammatory basis of trauma/ shock-associated multiple organ failure. Inflamm Res 47:201-210, 1998.
39. Cochrane CG: Mechanisms of oxidant injury of cells. Mol Aspects Med 12:137-147, 1991.
40. Szabo C, Zingarelli B, O'Connor M, Salzman AL: DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A 93:1753-1758, 1996.
41. Szabo C, Lim LH, Cuzzocrea S, Getting SJ, Zingarelli B, Flower RJ, Salzman AL, Perretti M: Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J Exp Med 186:1041-1049, 1997.